AKT1 and Insulin resistance: As shown in Figure 1, icariin treatment protected C2C12 myotubes against PA-induced insulin resistance in a dose-dependent manner, as demonstrated by the gradual recoveries of insulin-stimulated phosphorylation of Akt at Thr308 and of its downstream substrate AS160 (Figures 1A,B).